Welcome to our dedicated page for Core Scientific SEC filings (Ticker: CORZZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Core Scientific filings document the company’s public reporting for its common stock and Nasdaq-listed warrants, including CORZZ tranche 2 warrants exercisable for common stock at a $0.01 exercise price. The records identify Core Scientific as a digital infrastructure business with bitcoin self-mining, digital asset hosting and high-density colocation operations.
Recent 8-K filings cover operating and financial results, Regulation FD materials, material definitive agreements, securities registered under Section 12(b), senior secured notes due 2031, capital-structure disclosures, subsidiary financing arrangements and governance matters such as officer appointments and compensation arrangements.
Core Scientific, Inc. ownership disclosure: a group of affiliated broker‑dealers led by Susquehanna entities reports beneficial ownership of 14,631,891 shares, representing 4.6% of the class. The filing states 315,594,802 Shares outstanding as of March 23, 2026. The reported holdings include option and warrant positions: 12,963,500 options and various warrants and options held across the reporting entities. The filing is a joint Schedule 13G/A by G1 Execution Services, LLC; SIG Brokerage, LP; Susquehanna Investment Group; and Susquehanna Securities, LLC, and includes a joint filing agreement.
Core Scientific, Inc. officer Todd M. Duchene reported selling 10,000 shares of Common Stock on May 11, 2026 in open-market transactions. The sales occurred in two blocks at weighted average prices of $22.8162 and $23.3916 per share. The filing states the trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, indicating the transactions were scheduled in advance rather than timed discretionarily. After these sales, Duchene continues to hold a substantial direct equity position in the company, so the activity represents a small portion of his overall holdings.
Core Scientific, Inc. reported sharply higher Q1 2026 revenue of $115.2 million, up from $79.5 million a year earlier, driven mainly by high-density colocation services. Colocation revenue rose to $77.5 million with a 57% gross margin, reflecting rapid expansion of AI and HPC-focused data centers.
The company recorded a net loss of $347.2 million, compared with net income of $576.3 million in Q1 2025, primarily due to $266.5 million of non-cash impairment charges on mining equipment and infrastructure as it pivots away from bitcoin self-mining. Digital asset self-mining revenue fell to $30.1 million and generated a negative gross margin.
Cash, cash equivalents and restricted cash increased to $1.15 billion, largely from a new $1.0 billion term loan facility, later refinanced via a $3.30 billion 7.75% senior secured notes issuance. Total liabilities reached $4.38 billion, and stockholders’ deficit widened to $1.31 billion. Deferred revenue climbed to $654.2 million, reflecting substantial pre-funded colocation build-outs and long-term contracts.
Core Scientific, Inc. officer Todd M. Duchene reported selling 10,000 shares of the company’s common stock in open-market transactions. The sales occurred on May 4, 2026, at weighted-average prices of $21.53 for 100 shares and $20.8499 for 9,900 shares.
After these transactions, Duchene directly holds 1,980,348 shares of Core Scientific common stock. The filing notes the trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025, indicating they were scheduled in advance rather than timed discretionarily.
Core Scientific, Inc. reported strong top-line growth but a large loss for the first quarter of 2026 as it shifts toward high-density colocation services. Total revenue reached $115.2 million, up from $79.5 million a year earlier, driven by a surge in colocation revenue to $77.5 million from $8.6 million.
Digital asset self-mining revenue fell to $30.1 million from $67.2 million as the company continues its strategic move away from proprietary mining. Gross profit improved to $30.1 million from $8.2 million, but Core Scientific posted a net loss of $347.2 million versus net income of $576.3 million in the prior-year quarter, mainly due to $266.5 million of non-cash impairment charges and a $30.8 million non-cash loss on warrants and contingent value rights.
Non‑GAAP Adjusted EBITDA turned positive at $4.4 million compared with a loss of $6.1 million. Liquidity was $1.04 billion as of March 31, 2026, including $1.01 billion of cash and cash equivalents and $37.3 million of bitcoin. The company also highlighted a recently closed $3.3 billion 7.75% senior secured notes due 2031 and a total gross power capacity pipeline of 4.5 GW supporting its colocation growth strategy.
Core Scientific, Inc. announced that its subsidiary Core Scientific Finance I LLC completed a private offering of $3.3 billion aggregate principal amount of 7.750% senior secured notes due 2031. The notes priced at 99.250% of principal, with interest paid semi-annually each May 15 and November 15, starting November 15, 2026.
The issuer expects net proceeds of about $3.24 billion. It will fund a debt service reserve account and distribute the remaining proceeds to Core Scientific. Core Scientific plans to use a portion of those funds to fully repay borrowings under its delayed-draw bridge credit facility of up to $1.0 billion, including accrued interest and related fees.
The notes are senior secured obligations, guaranteed by the issuer’s five datacenter subsidiaries and secured by first‑priority liens on substantially all of their assets, specified equity interests, and certain parent assets. Principal amortizes semi‑annually at an initial rate of 11.50% per annum, and the indenture includes customary redemption, repurchase, covenant and event‑of‑default provisions, plus a completion guarantee by Core Scientific for specified datacenter projects.
Core Scientific, Inc. plans a major expansion of its Muskogee, Oklahoma campus by acquiring Polaris DS LLC’s assets through a merger structure for an approximate $421 million cash purchase price, plus up to $40 million more if an additional 40 megawatts of firm electric capacity becomes available by December 31, 2026.
The acquired entity will own about 40 acres of land, an electrical substation and electrical service agreements providing up to 440 megawatts of continuous power adjacent to Core Scientific’s existing data center. The deal is expected to close early in the third quarter of 2026, subject to customary regulatory and other conditions.
Core Scientific has already deposited $120 million in escrow toward the purchase price and outlines liquidated-damages scenarios if the merger terminates. In a related strategy, the company targets roughly 1.5 gigawatts of gross power and about 1.0 gigawatt of leasable power at Muskogee, supported by new construction and approximately 250 acres of secured land.
Core Scientific, Inc. has appointed Jorge Ray as its Principal Accounting Officer, effective May 7, 2026. He currently serves as Chief Accounting Officer, a role he has held since March 2026, and brings prior senior accounting experience from Raymond James Financial, BankUnited, KPMG, and PwC.
His compensation includes a base salary of $400,000, a target annual bonus equal to 40% of base salary, a one-time grant of restricted stock units valued at $600,000 that vest over three years, and a one-time signing bonus of $193,000, including $71,000 for relocation expenses.
Core Scientific, Inc. officer Todd M. Duchene sold 10,000 shares of Common Stock in an open-market transaction. The sale, executed on April 27, 2026, was made at a weighted average price of $20.939 per share under a pre-arranged Rule 10b5-1 trading plan adopted on December 5, 2025. Following this sale, Duchene directly holds 1,990,348 shares of Core Scientific common stock.
Vanguard Portfolio Management reported beneficial ownership of 18,843,184 shares of Core Scientific Inc. Common Stock (CUSIP 21874A106), representing 5.97% of the class. The filing shows Vanguard has sole voting power over 228,648 shares and sole dispositive power over 18,843,184 shares. The disclosure notes holdings include securities managed across Vanguard affiliates and funds. The Schedule 13G was signed on 04/29/2026.